Nature Communications (Feb 2022)

Nationally representative SARS-CoV-2 antibody prevalence estimates after the first epidemic wave in Mexico

  • Ana Basto-Abreu,
  • Martha Carnalla,
  • Leticia Torres-Ibarra,
  • Martín Romero-Martínez,
  • Jesús Martínez-Barnetche,
  • Irma López-Martínez,
  • Rodrigo Aparicio-Antonio,
  • Teresa Shamah-Levy,
  • Celia Alpuche-Aranda,
  • Juan A. Rivera,
  • Tonatiuh Barrientos-Gutierrez,
  • ENSANUT-COVID collaborators

DOI
https://doi.org/10.1038/s41467-022-28232-9
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 8

Abstract

Read online

SARS-CoV-2 seroprevalence surveys provide estimates of the extent of prior infection in a population. In this nationally representative survey from Mexico, the authors estimate seroprevalence after the first epidemic wave at ~25%, with variation by region, age, socioeconomic status, and education level.